REFERENCES
Doubrovsky A, de Wilt JHW, Scolyer RA, McCarthy WH, Thompson JF. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol 2004;11:829–36.
McMasters KM, Wong SL, Edwards MJ, et al. Factors that predict the presence of a positive sentinel lymph node metastasis in patients with melanoma. Surgery 2001;130:151–6.
Chao C, RCG Martin 2nd, Ross MI, et al. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 2004;11:259–64.
Carlson GW. Age and the incidence of sentinel lymph node metastases in melanoma. Ann Surg Oncol 2004;11:236–7.
Shields JD, Borsetti M, Rigby H, et al. Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer 2004;9:90:693–700.
Valencak J, Heere-Ress E, Kopp T, Schoppmann SF, Kittler H, Pehamberger H. Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. Eur J Cancer 2004;40:358–64.
Chao C, Edwards MJ, Abell T, Wong SL, Simpson DR, McMasters KM. Palpable breast carcinomas: a hypothesis for clinically relevant lymphatic drainage in sentinel lymph node biopsy. Breast J 2003;9:26–32.
Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192–8.
Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001;7:186–91.
Dadras SS, Paul T, Bertoncini J, et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003;162:1951–60.
Isaka J, Padera TP, Hagendoorn J, Fukumura D, Jain RK. Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function. Cancer Res 2004;64:4400–04.
Chao C, Lentsch E, Wong SL, et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol 2003;10:21–6.
Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999;230:453–63.
Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol. 2004;11(Suppl 3):162S-8S
Carlson GW, Murray DR, Lyles RH, Staley CA, Heltsley A, Cohen C. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance?. Ann Surg Oncol 2003;10:575–81.
Chao C, Wong SL, Ross MI and for the Sunbelt Melanoma Trial Group. et al. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 2002;184:520–24.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McMasters, K.M. What Good is Sentinel Lymph Node Biopsy for Melanoma if it does not Improve Survival?. Ann Surg Oncol 11, 810–812 (2004). https://doi.org/10.1245/ASO.2004.07.919
Issue Date:
DOI: https://doi.org/10.1245/ASO.2004.07.919